ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,101.24
-0.29%
Dow Jones
44,424.25
-0.32%
US Dollar vs MXN
20.2749
0.00%
Brent Oil
77.625
0.00%
Bitcoin
105,129.96
0.38%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Harrow Inc (HROWM) Cotización

Harrow Inc

Harrow Inc (HROWM)

NASDAQ
26.81
0.06
(0.22%)
Cerrado 26 Enero 3:00PM
Delayed by 15 minutes
26.81
0.00
(0.00%)
Fuera de horario: 5:50PM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
26.81
Postura de Compra
26.78
Postura de Venta
27.63
Volume Operado de la Acción
386
26.80 Rango del Día 26.82
25.29 Rango de 52 semanas 27.72
Capitalización de Mercado [m]
954.831M
Precio Anterior
26.75
Precio de Apertura
26.82
Hora
25
@
26.82
Última hora de negociación
Volumen financiero
US$ 10,348
Precio Promedio Ponderado
26.8072
Volumen promedio (3 m)
3,153
Acciones en circulación
35,614,718
Rendimiento del Dividendo
11.07%
Ratio Precio/Utilidad
-36.62
Beneficio por acción (BPA)
-0.69
turnover
130.19M
Beneficio neto
-24.41M

Acerca de Harrow Inc

Harrow Health Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Drople... Harrow Health Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.harrow.com
Sede
Dover, Delaware, USA
Fundado
-
Harrow Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HROWM. The last closing price for Harrow was US$26.75. Over the last year, Harrow shares have traded in a share price range of US$ 25.29 to US$ 27.72.

Harrow currently has 35,614,718 shares in issue. The market capitalisation of Harrow is US$952.69 million. Harrow has a price to earnings ratio (PE ratio) of -36.62.

HROWM Últimas noticias

Más noticias

Form 4 - Statement of changes in beneficial ownership of securities

24 Enero 2025
Edgar (US Regulatory)

Form 8-K - Current report

21 Enero 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

08 Enero 2025
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

08 Enero 2025
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

05 Diciembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

14 Noviembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

14 Noviembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

28 Octubre 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

08 Octubre 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.210.78947368421126.627.0526.58267126.80830322CS
40.843.2345013477125.9727.1825.8357926.50168942CS
120.752.8779739063726.0627.1825.8315326.33876208CS
260.762.9174664107526.0527.2525.3381826.28895889CS
521.335.2197802197825.4827.7225.29383426.29144523CS
1562.319.4285714285724.527.7222.71788225.32555645CS
2602.319.4285714285724.527.7222.71788225.32555645CS

HROWM - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Harrow?
El precio actual de las acciones de Harrow es US$ 26.81
¿Cuántas acciones de Harrow están en circulación?
Harrow tiene 35,614,718 acciones en circulación
¿Cuál es la capitalización de mercado de Harrow?
La capitalización de mercado de Harrow es USD 952.69M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Harrow?
Harrow ha negociado en un rango de US$ 25.29 a US$ 27.72 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Harrow?
El ratio precio/beneficio de Harrow es -36.62
¿Cuál es el ratio de efectivo a ventas de Harrow?
El ratio de efectivo a ventas de Harrow es 6.87
¿Cuál es la moneda de reporte de Harrow?
Harrow presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Harrow?
El último ingresos anual de Harrow es USD 130.19M
¿Cuál es el último beneficio anual de Harrow?
El último beneficio anual de Harrow es USD -24.41M
¿Cuál es la dirección registrada de Harrow?
La dirección registrada de Harrow es 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
¿Cuál es la dirección del sitio web de Harrow?
La dirección del sitio web de Harrow es www.harrow.com
¿En qué sector industrial opera Harrow?
Harrow opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
EVAXEvaxion Biotech AS
US$ 5.99
(64.56%)
55.41M
ELABPMGC Holdings Inc
US$ 3.0901
(56.07%)
76.48M
PCLAPicoCELA Inc
US$ 4.60
(49.35%)
3.75M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
GODNUGolden Star Acquisition Corporation
US$ 3.11
(-75.82%)
17.51k
GODNGolden Star Acquisition Corporation
US$ 2.93
(-65.67%)
902.76k
NXTTNext Technology Holding Inc
US$ 1.37
(-54.93%)
2.56M
SGLYSingularity Future Technology Ltd
US$ 1.625
(-38.45%)
917.77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90.11
(-38.07%)
8
ACONAclarion Inc
US$ 0.0557
(28.94%)
811.91M
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
RIMEAlgorhythm Holdings Inc
US$ 0.0357
(4.69%)
284.97M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
NVDANVIDIA Corporation
US$ 142.62
(-3.12%)
232.88M

Discusión

Ver feed completo
dinogreeves dinogreeves 6 minutos hace
I would like to think earnings will be announced this week sometime, on the flip side investors/traders like to think that if Supermicro was to announce earnings this week, they would have posted it on the website, there is no way of knowing the managements game plan, I know if my companies stock wa
SMCI
KngmAz KngmAz 7 minutos hace
Not necessarily. GOEV still has a lot of very valuable and very salable assets. Stay Tuned.
GOEV
igotthemojo igotthemojo 7 minutos hace
instead of publicly whining, how about countering some of his opinions with well thought out replies...
PLUG
Monksdream Monksdream 7 minutos hace
SFM 1 yr
https://investorshub.advfn.com/uimage/uploads/2025/1/26/sgouzIMG_4871.gif
SFM
sab63090 sab63090 8 minutos hace
CrypticDomain141
I just did and I think he was referring to the Peer Review which now know is favorable! I liked his comment on CONDITIONAL approval, too, he added that here in Europe we don't have anything that compares as favorablty....no MRI's, infusions, etc.....he did say he could not to
AVXL
Dingbatt Dingbatt 9 minutos hace
Interesting post
Was this held up by DEI rules
GNCP
Monksdream Monksdream 9 minutos hace
TSLA, 10Q due 1/29
https://investorshub.advfn.com/uimage/uploads/2025/1/26/exeszIMG_4870.gif
TSLA
Smartypants2 Smartypants2 10 minutos hace
Of course XTI's obligation to didn't expire with the merger! Don't forget, XERI orchestrated the merger along with Maxim. The joint venture between XERI and XTI had NOTHING to do with the merger. It was strictly for the funding of the PDR. The merger agreement was totally separate! How can you fail
XERI
88TH MAN 88TH MAN 11 minutos hace
T-minus three days, and counting, till the "Chinese New Year", and the "Parade Of Planets 2025" during a "New Moon".
FBEC
Bigfootbud Bigfootbud 11 minutos hace
Blessed is the one... whose delight is in the law of the Lord, and who meditates on his law day and night.
—Psalm 1:1-2
al44 al44 12 minutos hace
This is how to do it-

From President Donald J. Trump -

I was just informed that two repatriation flights from the United States, with a large number of Illegal Criminals, were not allowed to land in Colombia. This order was given by Colombia’s Socialist President Gustav
Monksdream Monksdream 12 minutos hace
CRK, 1 yr
https://investorshub.advfn.com/uimage/uploads/2025/1/26/wpsvrIMG_4869.gif
CRK
buylow2 buylow2 13 minutos hace
Hey Chazzy, what amazing patent are u talking about. Can’t ever remember Hdvy making a cent on any of them.
HDVY
Researchfyi Researchfyi 13 minutos hace
I don’t believe for a second that the owners of the 4 LCC’s bought 28 million USD of shares with no expectation of a significant return on their investment. They must know something is coming whether Apple or something else.


Just about the exact same thing was said about a man
LQMT
Ayock Ayock 14 minutos hace
PRAISE BE...
https://scontent-lax3-2.xx.fbcdn.net/v/t39.30808-6/475359003_1037232521779460_6408379799425909766_n.jpg?stp=cp6_dst-jpg_tt6&_nc_cat=107&ccb=1-7&_nc_sid=833d8c&_nc_ohc=PPRGRdjGRrEQ7kNvgHvQh3C&_nc_zt=23&_nc_ht=scontent-lax3-2.xx&_nc_gid=Al8shBJZ-MairJaFyjeapza&oh=00_AYDGLy0OiKMPlYK
Eli's Gone Eli's Gone 14 minutos hace
Dunno---
https://en.wikipedia.org/wiki/Cook_Out_Clash_at_Bowman_Gray_Stadium

plenty to choose from:
https://en.wikipedia.org/wiki/List_of_NASCAR_tracks
frrol frrol 14 minutos hace
Thanks for that link. Not "AD/Dementia" but "ADL", which is an endpoint for measuring functional decline (as opposed to cognitive decline).

Given that AD is such a complex disease, it will very likely require combination treatments, ie more than one drug, for broadly effective treatme
AVXL
georgie18 georgie18 15 minutos hace
SCPCF...438...🥳... https://schrts.co/bkDvMMJi ...Bullish Harami Reversal Pattern... OTC...Quantum ticker with 50 Million O/S...
SCPCF
ddls ddls 15 minutos hace
I don't spend 24-7 researching BIEL problems but, something I didn't know is, that they have 120 after December 31st. to report financials on OTC Pink Limited.😎

They may not report then either. I wouldn't be surprised.
BIEL
BlazingStocks BlazingStocks 16 minutos hace
$ILLR - Triller is in the process of capturing unprecedented opportunities in the social media industries through our unique offerings that are singularly focused on generating value for all stakeholders in the creator economy.
https://finance.yahoo.com/news/triller-group-inc-unveils-bold-140
ILLR
PEACHMAN PEACHMAN 16 minutos hace
Is that all you can say ?IFUS will make me a millionaire in 2025 because it is a legitimate business that will generate more sales and revenues with Joint Venture in India than the POS removed board member ever thought possible

https://investorshub.advfn.com/uimage/uploads/2025/1/26/i
IFUS
Truth_is_a_tool Truth_is_a_tool 16 minutos hace
🤣 That or purposefully misleading.
KBLB
BDEZ BDEZ 18 minutos hace
CA FORCED CLOSED 12 generational dairy farms in Marin County. The residents speak out

California DIDN’T ALLOW IN people who could object, “We had the wrong people in the room making decisions and everybody else not

https://x.com/WallStreetApes/status/1883593979100311787

Su Consulta Reciente

NASDAQ
HROWM
Harrow
BIT
SISP5S
SG Issuer Societe Generale
BIT
UC7PXN
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados